股本结构
单位：万股
| 公告日期 | 2026-09-28 | 2026-08-13 | 2026-08-10 | 2026-08-07 | 2026-05-14 | 2026-04-15 |
|---|---|---|---|---|---|---|
| 证券总股本 | 87.84 | 72.85 | 480.00 | 539.48 | 481.82 | 463.98 |
| 普通股本 | 87.84 | 72.85 | 480.00 | 539.48 | 481.82 | 463.98 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-09-28 | 2026-08-13 | 2026-08-10 | 2026-08-06 | 2026-03-31 | 2025-12-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-09-28 | 87.84 | 未披露 | 定期报告 | 2026-09-28 |
| 2026-08-13 | 72.85 | 未披露 |
更多>>
a one-for-eight reverse stock split of its common stock
|
2026-08-13 |
| 2026-08-10 | 480.00 | 未披露 | 定期报告 | 2026-08-10 |
| 2026-08-07 | 539.48 | 未披露 | 定期报告 | 2026-08-06 |
| 2026-05-14 | 481.82 | 未披露 |
更多>>
From January 1, 2026 to March 31, 2026
Issuance of shares pursuant to At The Market Offering Agreement - net of $7 issuance cost
|
2026-03-31 |
| 2026-04-15 | 463.98 | 未披露 |
更多>>
From December 31,2024 to December 31,2025
Stock-based compensation related to options and restricted shares granted to employees and consultants
Issuance of shares pursuant to At The Market Offering Agreement for - net of $117 issuance costs
Investment in Shoe Size Me
|
2025-12-31 |
| 2025-11-14 | 384.90 | 未披露 |
更多>>
From July 1, 2025 to September 30, 2025
Issuance of shares pursuant to At The Market Offering Agreement for - net of $37 issuance cost
Investment Shoe Size Me
|
2025-09-30 |
| 2025-09-12 | 349.80 | 未披露 |
更多>>
MySize issued an aggregate of 241,093 shares of common stock to the sellers of ShoeSize
|
2025-09-08 |
| 2025-08-14 | 325.69 | 未披露 | 定期报告 | 2025-08-14 |
| 2025-05-15 | 310.31 | 未披露 | 定期报告 | 2025-05-15 |
| 2025-03-27 | 211.07 | 未披露 | 定期报告 | 2025-03-10 |
| 2025-03-27 | 204.02 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Stock-based compensation related to options and restricted shares granted to employees and consultants
Issuance of shares for sellers post Business Combination
Effect of reverse stock split
Issuance of shares, net of issuance cost of $442
Exercise of shares in abeyance
Exercise of Warrants
|
2024-12-31 |
| 2024-11-04 | 126.01 | 未披露 | 定期报告 | 2024-11-04 |
| 2024-11-14 | 116.91 | 未披露 |
更多>>
From July 1, 2024 to September 30, 2024
Exercise of shares in abeyance
|
2024-09-30 |
| 2024-08-12 | 106.71 | 未披露 | 定期报告 | 2024-08-01 |
| 2024-06-04 | 88.31 | 未披露 | 定期报告 | 2024-06-03 |
| 2024-05-15 | 64.15 | 未披露 | 定期报告 | 2024-05-10 |
| 2024-04-15 | 64.00 | 未披露 |
更多>>
1-for-8 reverse stock split of the Company’s issued and outstanding shares of common stock
|
2024-04-23 |
| 2024-04-15 | 510.00 | 未披露 | 定期报告 | 2024-04-15 |
| 2024-04-01 | 509.17 | 未披露 | 定期报告 | 2024-03-10 |
| 2024-03-22 | 513.17 | 未披露 | 定期报告 | 2024-03-08 |
| 2023-12-22 | 362.18 | 未披露 | 定期报告 | 2023-12-21 |
| 2023-11-14 | 298.18 | 未披露 |
更多>>
From January 1, 2023 to September 30, 2023
Stock-based compensation related to options granted to employees and consultants
Issuance of shares, net of issuance cost of $959,000
Exercise of warrants and prefunded warrants
|
2023-09-30 |
| 2023-09-13 | 445.68 | 未披露 | 定期报告 | 2023-09-12 |
| 2023-08-14 | 243.88 | 未披露 |
更多>>
From January 1, 2023 to June 30, 2023
Stock-based compensation related to options granted to employees and consultants
Issuance of shares, net of issuance cost of $341
Exercise of warrants and prefunded warrants
|
2023-06-30 |
| 2023-05-15 | 244.68 | 未披露 |
更多>>
From January 1, 2023 to March 31, 2023
Exercise of warrants and prefunded warrants
Issuance of shares, net of issuance cost of $341
|
2023-03-31 |
| 2023-01-12 | 162.61 | 未披露 |
更多>>
Shares of common stock offered 162,000 shares by the company
|
2023-01-12 |
| 2023-04-14 | 146.41 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Stock-based compensation related to options and restricted shares granted to employees and consultants
Issuance of shares in Business Combination
Effect of reverse stock split
Issuance of shares post Business Combination
|
2022-12-31 |
| 2022-12-07 | 150.00 | 未披露 |
更多>>
MySize, Inc. announced that its Board of Directors has approved a one-for-twenty-five reverse stock split of its common stock that is scheduled to become effective after trading closes on December 8, 2022.
|
2022-12-09 |
| 2022-11-04 | 3612.63 | 未披露 | 定期报告 | 2022-10-24 |
| 2022-11-14 | 2572.63 | 未披露 |
更多>>
From July 1, 2022 to September 30, 2022
Issuance of shares in Business Combination
|
2022-09-30 |
| 2022-08-15 | 2555.19 | 未披露 |
更多>>
From April 1, 2022 to June 30, 2022
Issuance of shares in Business Combination
|
2022-06-30 |
| 2022-03-18 | 2537.75 | 未披露 | 定期报告 | 2022-03-14 |
| 2022-03-18 | 2398.25 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Exercise of options granted to employees
Exercise of warrants
Restricted shares issued to shareholder
Issuance of shares, net of issuance cost of $1,160
|
2021-12-31 |
| 2021-10-29 | 2021.03 | 未披露 |
更多>>
1.Shares of common stock offered by company 2,514,800 shares.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 17,695,495 shares of common stock outstanding as of October 26, 2021.
|
2021-10-29 |
| 2021-10-28 | 1769.55 | 未披露 | 定期报告 | 2021-10-26 |
| 2021-11-15 | 1506.96 | 未披露 |
更多>>
From July 1, 2021 to September 30, 2021
Exercise of options granted to employees
Exercise of warrants
|
2021-09-30 |
| 2021-08-16 | 1504.22 | 未披露 | 定期报告 | 2021-08-11 |
| 2021-06-24 | 1503.83 | 未披露 | 定期报告 | 2021-06-24 |
| 2021-05-14 | 1253.83 | 未披露 | 定期报告 | 2021-05-11 |
| 2021-05-14 | 1214.55 | 未披露 |
更多>>
1.Shares of common stock offered by the company 2,618,532 shares.
2.The number of shares of common stock to be outstanding immediately before this offering is based on 9,527,015 shares of common stock outstanding as of March 19, 2021.
From January 1, 2021 to March 25, 2021
Issuance of shares, net of issuance cost of $736
Exercise of warrants
|
2021-03-25 |
| 2021-03-22 | 952.70 | 未披露 | 定期报告 | 2021-03-19 |
| 2021-01-08 | 859.73 | 未披露 |
更多>>
1.Shares of common stock offered by the company 1,364,503 shares of common stock.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 7,232,836 shares of common stock outstanding as of September 30, 2020.
|
2021-01-08 |
| 2020-11-12 | 723.28 | 未披露 |
更多>>
From July 1, 2020 to Auguest 4, 2020
Exercise of warrants
|
2020-08-04 |
| 2020-08-13 | 715.78 | 未披露 |
更多>>
From January 1, 2020 to June 30, 2020
Issuance of shares, net of issuance cost of $1,160
Exercise of warrants and pre funded warrants
|
2020-06-30 |
| 2020-05-14 | 714.62 | 未披露 | 定期报告 | 2020-05-14 |
| 2020-05-14 | 260.07 | 未披露 |
更多>>
From December 31, 2019 to January 17, 2020
1.Shares of common stock offered by us 514,801 shares of common stock.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 2,085,900 shares of common stock outstanding as of January 14, 2020
Issuance of shares, net of issuance cost of $358
|
2020-01-17 |
| 2020-01-17 | 208.59 | 未披露 | 定期报告 | 2020-01-14 |
| 2020-03-19 | 199.22 | 未披露 |
更多>>
from December 31,2018 to December 31, 2019
Issuance of shares to consultants
Issuance of shares, net of issuance cost of $138
Reverse Stock Split
|
2019-12-31 |
| 2019-11-19 | 200.00 | 未披露 |
更多>>
The reverse stock split will not affect any stockholder’s ownership percentage of the Company’s common stock, except to the extent that the reverse stock split would result in any stockholder owning a fractional share. Fractional shares of common stock will be rounded up to the nearest whole share. The number of authorized shares of the Company’s common stock will not change, while the number of outstanding shares will be reduced from approximately 30 million to approximately 2 million.
|
2019-11-19 |
| 2019-08-08 | 2988.36 | 未披露 |
更多>>
from April 1, 2019 to May 10,2019
Issuance of shares to consultants
|
2019-05-10 |
| 2019-03-27 | 2985.24 | 未披露 |
更多>>
from December 31, 2017 to November 16, 2018
Issuance of shares to consultants
Exercise of warrants and options
Liability reclassified to equity
Issuance and receipts on account of shares, net of issuance cost of $351
|
2018-11-16 |
| 2018-11-19 | 2971.00 | 未披露 |
更多>>
From January 1, 2018 to August 13, 2018
Issuance of shares to consultants
Exercise of warrants and options
Liability reclassified to equity
Issuance and receipts on account of shares, net of issuance cost of $351
|
2018-08-13 |
| 2018-08-13 | 2967.88 | 未披露 |
更多>>
from January 1, 2018 to June 30, 2018
Issuance of shares to consultants
Exercise of warrants and options
Issuance and receipts on account of shares, net of issuance cost of $351
Liability reclassified to equity
|
2018-06-30 |
| 2018-05-11 | 2955.27 | 未披露 | 定期报告 | 2018-05-11 |
| 2018-05-18 | 2925.70 | 未披露 | 定期报告 | 2018-04-09 |
| 2018-05-11 | 2914.59 | 未披露 |
更多>>
from January 1, 2018 to March 19, 2018
Issuance of shares to consultants
Exercise of warrants and options
Issuance and receipts on account of shares, net of issuance cost of $351
|
2018-03-19 |
| 2018-01-12 | 2346.44 | 未披露 | 定期报告 | 2018-01-09 |
| 2018-03-21 | 2223.87 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of shares to consultants
Liability reclassified to equity
Issuance and receipts on account of shares, net of issuance cost of $360
|
2017-12-31 |
| 2017-12-18 | 1840.62 | 未披露 | 定期报告 | 2017-12-12 |
| 2017-10-27 | 1839.48 | 未披露 | 定期报告 | 2017-10-27 |
| 2017-11-13 | 1807.82 | 未披露 |
更多>>
From January 1, 2017 to September 30, 2017
Warrants converted and exercised into equity
Issuance and receipts on account of shares
|
2017-09-30 |
| 2017-05-16 | 1760.54 | 未披露 |
更多>>
From January 1, 2017 to March 1, 2017
Receipts on account of shares and New investments
|
2017-03-01 |
| 2016-11-21 | 1740.54 | 未披露 |
更多>>
from January 1, 2016 to September 30, 2016
Convertible loans converted to equity
|
2016-09-30 |
| 2016-08-15 | 1684.24 | 未披露 | 定期报告 | 2016-08-12 |
| 2016-05-23 | 1531.38 | 未披露 | 定期报告 | 2016-03-31 |
a one-for-eight reverse stock split of its common stock
From January 1, 2026 to March 31, 2026
Issuance of shares pursuant to At The Market Offering Agreement - net of $7 issuance cost
From December 31,2024 to December 31,2025
Stock-based compensation related to options and restricted shares granted to employees and consultants
Issuance of shares pursuant to At The Market Offering Agreement for - net of $117 issuance costs
Investment in Shoe Size Me
From July 1, 2025 to September 30, 2025
Issuance of shares pursuant to At The Market Offering Agreement for - net of $37 issuance cost
Investment Shoe Size Me
MySize issued an aggregate of 241,093 shares of common stock to the sellers of ShoeSize
From December 31, 2023 to December 31, 2024
Stock-based compensation related to options and restricted shares granted to employees and consultants
Issuance of shares for sellers post Business Combination
Effect of reverse stock split
Issuance of shares, net of issuance cost of $442
Exercise of shares in abeyance
Exercise of Warrants
From July 1, 2024 to September 30, 2024
Exercise of shares in abeyance
1-for-8 reverse stock split of the Company’s issued and outstanding shares of common stock
From January 1, 2023 to September 30, 2023
Stock-based compensation related to options granted to employees and consultants
Issuance of shares, net of issuance cost of $959,000
Exercise of warrants and prefunded warrants
From January 1, 2023 to June 30, 2023
Stock-based compensation related to options granted to employees and consultants
Issuance of shares, net of issuance cost of $341
Exercise of warrants and prefunded warrants
From January 1, 2023 to March 31, 2023
Exercise of warrants and prefunded warrants
Issuance of shares, net of issuance cost of $341
Shares of common stock offered 162,000 shares by the company
From December 31, 2021 to December 31, 2022
Stock-based compensation related to options and restricted shares granted to employees and consultants
Issuance of shares in Business Combination
Effect of reverse stock split
Issuance of shares post Business Combination
MySize, Inc. announced that its Board of Directors has approved a one-for-twenty-five reverse stock split of its common stock that is scheduled to become effective after trading closes on December 8, 2022.
From July 1, 2022 to September 30, 2022
Issuance of shares in Business Combination
From April 1, 2022 to June 30, 2022
Issuance of shares in Business Combination
From December 31, 2020 to December 31, 2021
Exercise of options granted to employees
Exercise of warrants
Restricted shares issued to shareholder
Issuance of shares, net of issuance cost of $1,160
1.Shares of common stock offered by company 2,514,800 shares.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 17,695,495 shares of common stock outstanding as of October 26, 2021.
From July 1, 2021 to September 30, 2021
Exercise of options granted to employees
Exercise of warrants
1.Shares of common stock offered by the company 2,618,532 shares.
2.The number of shares of common stock to be outstanding immediately before this offering is based on 9,527,015 shares of common stock outstanding as of March 19, 2021.
From January 1, 2021 to March 25, 2021
Issuance of shares, net of issuance cost of $736
Exercise of warrants
1.Shares of common stock offered by the company 1,364,503 shares of common stock.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 7,232,836 shares of common stock outstanding as of September 30, 2020.
From July 1, 2020 to Auguest 4, 2020
Exercise of warrants
From January 1, 2020 to June 30, 2020
Issuance of shares, net of issuance cost of $1,160
Exercise of warrants and pre funded warrants
From December 31, 2019 to January 17, 2020
1.Shares of common stock offered by us 514,801 shares of common stock.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 2,085,900 shares of common stock outstanding as of January 14, 2020
Issuance of shares, net of issuance cost of $358
from December 31,2018 to December 31, 2019
Issuance of shares to consultants
Issuance of shares, net of issuance cost of $138
Reverse Stock Split
The reverse stock split will not affect any stockholder’s ownership percentage of the Company’s common stock, except to the extent that the reverse stock split would result in any stockholder owning a fractional share. Fractional shares of common stock will be rounded up to the nearest whole share. The number of authorized shares of the Company’s common stock will not change, while the number of outstanding shares will be reduced from approximately 30 million to approximately 2 million.
from April 1, 2019 to May 10,2019
Issuance of shares to consultants
from December 31, 2017 to November 16, 2018
Issuance of shares to consultants
Exercise of warrants and options
Liability reclassified to equity
Issuance and receipts on account of shares, net of issuance cost of $351
From January 1, 2018 to August 13, 2018
Issuance of shares to consultants
Exercise of warrants and options
Liability reclassified to equity
Issuance and receipts on account of shares, net of issuance cost of $351
from January 1, 2018 to June 30, 2018
Issuance of shares to consultants
Exercise of warrants and options
Issuance and receipts on account of shares, net of issuance cost of $351
Liability reclassified to equity
from January 1, 2018 to March 19, 2018
Issuance of shares to consultants
Exercise of warrants and options
Issuance and receipts on account of shares, net of issuance cost of $351
from December 31, 2016 to December 31, 2017
Issuance of shares to consultants
Liability reclassified to equity
Issuance and receipts on account of shares, net of issuance cost of $360
From January 1, 2017 to September 30, 2017
Warrants converted and exercised into equity
Issuance and receipts on account of shares
From January 1, 2017 to March 1, 2017
Receipts on account of shares and New investments
from January 1, 2016 to September 30, 2016
Convertible loans converted to equity